Clofibrate-induced reduction of plasma branched-chain amino acid concentrations impairs glucose tolerance in rats

Journal of Parenteral and Enteral Nutrition

Volumn 36, Issue 3, 2012, Pages 337-343

  Kadota, Yoshihiro ^a   Kazama, Shunsuke ^a   Bajotto, Gustavo ^a   Kitaura, Yasuyuki ^a   Shimomura, Yoshiharu ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

keto acid dehydrogenase complex; keto acid dehydrogenase kinase; branched chain ; branched chain amino acids; clofibrate; glucose tolerance

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); BRANCHED CHAIN AMINO ACID; CLOFIBRATE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; IMPAIRED GLUCOSE TOLERANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; BLOOD GLUCOSE; CLOFIBRATE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPOLIPIDEMIC AGENTS; LIVER; MALE; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 84860282001     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111414578     Document Type: Article

References (38)

1. Tom A, Nair KS. Assessment of branched-chain amino acid status and potential for biomarkers. J Nutr. 2006 ; 136: 324S - 330S (Pubitemid 43156533)
2. Kimball SR, Jefferson LS. Signaling pathways and molecular mechanisms through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr. 2006 ; 136: S227 - S231
3. Matthews DE. Observation of branched-chain amino acid administration in humans. J Nutr. 2005 ; 135 (suppl 6). 1580-1584
4. Layman DK, Walker DA. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J Nutr. 2006 ; 136: 319S - 323S (Pubitemid 43156532)
5. Nishimura J, Masaki T, Arakawa M, Seike M, Yoshimatsu H. Isoleucine prevents the accumulation of tissue triglycerides and upregulates the expression of PPAR alpha and uncoupling protein in diet-induced obese mice. J Nutr. 2010 ; 140: 496-500
6. Nishitani S, Matsumura T, Fujitani S, Sonaka I, Miura Y, Yagasaki K. Leucine promotes glucose uptake in skeletal muscles of rats. Biochem Biophys Res Commun. 2002 ; 299: 693-696 (Pubitemid 36034542)
7. Doi M, Yamaoka I, Nakayama M, Sugahara K, Yoshizawa F. Hypoglycemic effect of isoleucine involves increased muscle glucose uptake and whole body glucose oxidation and decreased hepatic gluconeogenesis. Am J Physiol Endocrinol Metab. 2007 ; 292: E1683 - E1693 (Pubitemid 47084704)
8. Doi M, Yamaoka I, Nakayama M, Mochizuki S, Sugahara K, Yoshizawa F. Isoleucine, a blood glucose-lowering amino acid, increases glucose uptake in rat skeletal muscle in the absence of increases in AMP-activated protein kinase activity. J Nutr. 2005 ; 135: 2103-2108 (Pubitemid 41298372)
9. Shimomura Y, Obayashi M, Murakami T, Harris RA. Regulation of branched-chain amino acid catabolism: nutritional and hormonal regulation of activity and expression of the branched-chain alpha-keto acid dehydrogenase kinase. Curr Opin Clin Nutr Metab Care. 2001 ; 4: 419-423 (Pubitemid 34755432)
10. Obayashi M, Sato Y, Harris RA, Shimomura Y. Regulation of the activity of branched-chain 2-oxo acid dehydrogenase (BCODH) complex by binding BCODH kinase. FEBS Lett. 2001 ; 491: 50-54 (Pubitemid 32171999)
11. Harper AE, Miller RH, Block KP. Branched-chain amino acid metabolism. Ann Rev Nutr. 1984 ; 4: 409-454
12. Joshi MA, Jeoung NH, Obayashi M. Impaired growth and neurological abnormalities in branched-chain alpha-keto acid dehydrogenase kinase-deficient mice. Biochem J. 2006 ; 400: 153-162 (Pubitemid 44763830)
13. Kobayashi R, Murakami T, Obayashi M, et al. Clofibric acid stimulates branched-chain amino acid catabolism by three mechanisms. Arch Biochem Biophys. 2002 ; 407: 231-240 (Pubitemid 35341053)
14. Ishiguro H, Katano Y, Nakano I, et al. Clofibrate treatment promotes branched-chain amino acid catabolism and decreases the phosphorylation state of mTOR, eIF4E-BP1, and S6K1 in rat liver. Life Sci. 2006 ; 17: 737-743 (Pubitemid 43975130)
15. Gustafson LA, Kuipers F, Wiegman C, Sauerwein HP, Romijn JA, Meijer AJ. Clofibrate improves glucose tolerance in fat-fed rats but decreases hepatic glucose consumption capacity. J Hepatol. 2002 ; 37: 425-431
16. She P, Reid TM, Bronson SK, et al. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. 2007 ; 6: 181-194 (Pubitemid 47324140)
17. Beckett PR, Hardin DS, Davis TA, Nguyen HV, Wray-Cahen D, Copeland KC. Spectrophometric assay for measuring branched-chain amino acid concentrations: application for measuring the sensitivity of protein metabolism to insulin. Anal Biochem. 1996 ; 240: 48-53 (Pubitemid 26292921)
18. Nakai N, Kobayashi R, Popov KM, Harris RA, Shimomura Y. Determination of branched-chain a-keto acid dehydrogenase activity state and branched-chain a-keto acid dehydrogenase kinase activity and protein in mammalian tissues. Methods Enzymol. 2000 ; 324: 48-62
19. Bajotto G, Murakami T, Nagasaki M, et al. Downregulation of the skeletal muscle pyruvate dehydrogenase complex in the Otsuka Long-Evans Tokushima Fatty rat both before and after the onset of diabetes mellitus. Life Sci. 2004 ; 75: 2117-2130 (Pubitemid 39092996)
20. Sugden MC, Holness MJ. Recent advances in mechanisms regulating glucose oxidation at the level of the pyruvate dehydrogenase complex by PDKs. Am J Physiol Endocrinol Metab. 2003 ; 284: E855 - E862 (Pubitemid 36444020)
21. Jeoung NH, Wu P, Joshi MA, et al. Role of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homeostasis during starvation. Biochem J. 2006 ; 397: 417-425 (Pubitemid 44187500)
22. Muto Y, Sato S, Watanabe A, et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res. 2006 ; 35: 204-214
23. Limberg B, Kommerell B. Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin. Gut. 1984 ; 25: 1291-1295 (Pubitemid 15201392)
24. Suzuki K, Kato A, Iwai M. Branched-chain amino acid treatment in patients with liver cirrhosis. Hepatol Res. 2004 ; 30S: 25-29
25. Charlton M. Branched-chain amino acid enriched supplements as therapy for liver disease. J Nutr. 2006 ; 136: 295S - 298S (Pubitemid 43156528)
26. Nishitani S, Takehana K, Fujitani S, Sonaka I. Branched-chain amino acids improve glucose metabolism in rats with liver cirrhosis. Am J Physiol Gastrointest Liver Physiol. 2005 ; 288: G1292 - G1300 (Pubitemid 40741084)
27. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation. 1998 ; 98: 2088-2093 (Pubitemid 28512236)
28. Strisower EH. The combined use of CPIB and thyroxine in treatment of hyperlipoproteinemias. Circulation. 1966 ; 33: 291-296
29. Mannaerts GP, Thomas J, Debeer LJ, McGarry JD, Foster DW. Hepatic fatty acid oxidation and ketogenesis after clofibrate treatment. Biochim Biophys Acta. 1978 ; 529: 201-211 (Pubitemid 8385207)
30. Forman BM, Chen J, Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A. 1997 ; 94: 4312-4317 (Pubitemid 27194238)
31. Pineau T, Hudgins WR, Liu L, et al. Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs. Biochem Pharmacol. 1996 ; 52: 659-667 (Pubitemid 126689788)
32. Holness MJ, Sugden MC. Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem Soc Trans. 2003 ; 31: 1143-1151 (Pubitemid 38030927)
33. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009 ; 9: 311-326
34. Schauder P, Zavelberg D, Langer K, Herbertz L. Sex-specific differences in plasma branched-chain keto acid levels in obesity. Am J Clin Nutr. 1987 ; 46: 58-60 (Pubitemid 17090027)
35. Solini A, Bonora E, Bonadonna R, Castellino P, DeFronzo RA. Protein metabolism in human obesity: relationship with glucose and lipid metabolism and with visceral adipose tissue. J Clin Endocrinol Metab. 1997 ; 82: 2552-2558 (Pubitemid 27337872)
36. Zhang Y, Guo K, LeBlanc RE, Loh D, Schwartz GJ, Yu YH. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes. 2007 ; 56: 1647-1654 (Pubitemid 46842599)
37. Kuzuya T, Katano Y, Nakano I, et al. Regulation of branched-chain amino acid catabolism in rat models for spontaneous type 2 diabetes mellitus. Biochem Biophys Res Commun. 2008 ; 373: 94-98
38. Doisaki M, Katano Y, Nakano I, et al. Regulation of hepatic branched-chain alpha-keto acid dehydrogenase kinase in a rat model for type 2 diabetes mellitus at different stages of the disease. Biochem Biophys Res Commun. 2010 ; 393: 303-307